Article
Busy by the BaySan Francisco offers variety of eating, shopping opportunities
Iantrek, Inc. announces 1-Year outcomes from the CREST Registry for bio-interventional glaucoma treatment
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Study: Elevated NLR and SII levels linked to higher risk of cystoid macular edema
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
4-Year research validates DOT 0.2 spectacle lenses as early myopia treatment
Enhancing precision in GA imaging
